据内媒消息，"非洲手机之王"传音控股将于3月12日启动香港上市NDR(非交易路演)，预期交易规模约 为5亿至10亿美元，目标2026年第二季度登陆港交所。 传音控股，于2025年12月2日在港交所递交招股书，中信证券为其独家保荐人、摩根大通为其财务顾 问；中信证券、摩根大通、中金公司、海通国际、德意志银行为其整体协调人。 根据弗若斯特沙利文，按2024年手机销量计，传音控股的手机产品在全球新兴市场排名第一，市场份额 达24.1%。 | 02/12/2025 | 深圳傳音控股股份有限公司 | | --- | --- | | | 02/12/2025 整體協調人公告 - 委任 [四 | | | 02/12/2025 申請版本(第一次呈交)全文檔案 四国 多檔案》 | 传音控股招股书链接： https://www1.hkexnews.hk/app/sehk/2025/107922/documents/sehk25120202498_c.pdf 版权声明：所有瑞恩资本Ryanben Capital的原创文章，转载须联系授权，并在文首/文末注明来源、作 者、微信ID，否则瑞恩将向其追究法律责任。部分文章推送时未能与原作 ...

Core Viewpoint - Pu Tai Lai (603659.SH), a company listed on A-shares from Shanghai Pudong New District, announced plans to issue H-shares and apply for listing on the main board of the Hong Kong Stock Exchange to enhance its global strategy and capital strength [2][9]. Group 1: Company Strategy - The company aims to leverage international capital market advantages to create a diversified capital platform and improve its overseas financing capabilities [2][9]. - The issuance of H-shares is intended to strengthen the company's capital strength and overall competitiveness, enhance brand image, and accelerate overseas business development [2][9]. Group 2: Business Overview - Pu Tai Lai is a comprehensive solution provider and platform enterprise for key materials and automation equipment in the new energy battery sector, with main businesses including anode materials, coated separators, PVDF and binders, nano-alumina, aluminum-plastic packaging films, and composite current collectors [2][9]. - The company also provides automation equipment and coating processing services for the new energy battery industry [2][9]. Group 3: Market Position - As of January 9, 2026, the company's total market capitalization is approximately 59.2 billion RMB [4][11]. - The company was listed on the Shanghai Stock Exchange on October 3, 2017 [4][11].

Core Viewpoint - Company Juhe Materials (688503.SH) plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international brand recognition and competitiveness, aligning with its internationalization strategy [3][9]. Group 1: Company Overview - Juhe Materials specializes in the research, production, and sales of new electronic pastes, primarily focusing on conductive pastes for photovoltaic cells [3][9]. - The company was listed on the Shanghai Stock Exchange on December 9, 2022, with a total market capitalization of approximately 14.328 billion CNY as of December 22, 2022 [3][9]. Group 2: Financial Metrics - As of the latest trading session, the stock reached a high of 60.16 CNY and a low of 56.20 CNY, with a closing price of 56.77 CNY [4][10]. - The trading volume was 12.47457 million shares, with a turnover of 729 million CNY, indicating a turnover rate of 6.21% [4][10]. - The company has a dynamic P/E ratio of 44.96 and a TTM P/E ratio of 60.73, with an earnings per share of 0.97 CNY [4][10].

Group 1 - Shenzhen Transsion Holdings Co., Ltd. (Transsion Holdings) has appointed J.P. Morgan Securities (Asia Pacific) Limited, China International Capital Corporation Hong Kong Securities Limited, Haitong International Securities Company Limited, and Deutsche Bank Hong Kong Branch as its overall coordinators for its IPO [2][12] - The company submitted its prospectus to the Hong Kong Stock Exchange on December 2, 2025, and has appointed CITIC Securities as the sole sponsor and J.P. Morgan as the financial advisor [2][12] Group 2 - Transsion Holdings, established in 2013, is a leading provider of smart terminal products and mobile internet services, primarily focusing on smartphone design, research, production, sales, and brand operation [3][13] - The company has a strong market presence in emerging markets, particularly in Africa, where it is known as the "King of Africa" due to its significant market share and brand influence [3][13] - In 2024, Transsion Holdings sold over 200 million smartphones, covering 100 countries and regions, and had 270 million monthly active users on its Transsion OS in the first half of 2025 [3][13] Group 3 - The shareholder structure before the Hong Kong listing shows that Transsion Investment, controlled by Mr. Zhu Zhaojiang, holds 46.71% of the shares [4][14] - Other significant shareholders include CSAML (6.22%), Beijing Chuanjiali (5.39%), and other A-share shareholders (41.68%) [4][14]

Core Viewpoint - Shenzhen Zhaowei Electromechanical Co., Ltd. has received approval from the China Securities Regulatory Commission for its overseas listing, allowing it to issue up to 69.05845 million ordinary shares on the Hong Kong Stock Exchange [3]. Company Overview - Zhaowei Electromechanical was established in 2001 and is a leading provider of integrated micro-drive and drive system solutions, primarily serving high-growth industries such as smart automobiles, robotics, consumer technology, medical technology, and advanced industrial manufacturing [4]. - The company was listed on the A-share market on December 4, 2020, and as of November 21, 2025, it has a total market capitalization of approximately RMB 24.7 billion [4]. - According to a report by Frost & Sullivan, Zhaowei Electromechanical ranked first in China and fourth globally in terms of revenue in 2024 [4]. IPO Details - The company submitted its prospectus to the Hong Kong Stock Exchange on June 18, 2025, with joint sponsors being China Merchants Securities International and Deutsche Bank [4].

Group 1 - Zejing Pharmaceutical (688266.SH) plans to issue overseas listed shares (H-shares) and apply for listing on the Hong Kong Stock Exchange to enhance its international brand recognition and competitiveness [1][2] - The company is currently in discussions with relevant intermediaries regarding the issuance and listing, with specific details yet to be finalized [1] - As of November 17, 2025, Zejing Pharmaceutical's total market capitalization is approximately 27.133 billion RMB [2] Group 2 - Established in 2009, Zejing Pharmaceutical has five subsidiaries and focuses on the independent research, production, and commercialization of innovative drugs [2] - The company aims to become a leader in the development and production of new drugs for oncology, bleeding and blood diseases, and immune-inflammatory diseases [2] - Zejing Pharmaceutical has developed two core technology platforms for small molecule drug research and complex recombinant protein new drugs, covering various cancers and treatment areas [2]

Group 1 - Spring Airlines, a low-cost carrier in China, is reportedly considering an IPO in Hong Kong next year, potentially raising several hundred million dollars [2] - The company has selected JPMorgan and UBS to handle the listing process [2] - As of June 2025, Spring Airlines operates 192 domestic routes and 55 international routes, making it one of the largest private airlines in China by passenger volume [2] Group 2 - Spring Airlines has a fleet of 133 A320 aircraft, positioning it as a leading low-cost airline in Northeast Asia [2] - The company was established in 2005 and focuses on domestic, international, and Hong Kong-Macau-Taiwan air transportation services [2]